Related Experiment Video
Updated: Jul 5, 2026
07:18
A Behavioral Test Battery for the Repeated Assessment of Motor Skills, Mood, and Cognition in Mice
Published on: March 2, 2019
Dementia care. Part 2: understanding and managing behavioural challenges
Emma Ouldred1, Catherine Bryant
1King's College Hospital NHS Trust, London.
British Journal of Nursing (Mark Allen Publishing)
|April 17, 2008
Summary
This study highlights non-pharmacological dementia management strategies, including reality orientation and aromatherapy, to maintain function and independence. It also emphasizes support for family caregivers experiencing high stress levels.
Area of Science:
- Gerontology
- Neurology
- Psychiatry
Background:
- Dementia management prioritizes maintaining patient function and independence.
- Non-pharmacological interventions are key for managing dementia and challenging behaviors.
- Caregivers of individuals with dementia often experience significant stress and psychological distress.
Purpose of the Study:
- To outline current approaches in dementia care.
- To highlight the role of non-pharmacological interventions.
- To underscore the importance of caregiver support.
Main Methods:
- Review of current dementia management guidelines.
- Discussion of non-pharmacological therapies such as reality orientation, aromatherapy, and validation therapy.
- Consideration of pharmacological treatments for Alzheimer's disease symptoms.
Main Results:
- Non-pharmacological methods are recommended for managing challenging behaviors in dementia.
- Pharmacological treatments may offer temporary symptom stabilization for Alzheimer's disease.
- Family caregivers face substantial psychological burdens.
Conclusions:
- A holistic approach to dementia care is essential, integrating non-pharmacological strategies.
- Effective management includes addressing the needs of both the individual with dementia and their caregivers.
- Healthcare practitioners play a vital role in connecting caregivers with support services.
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications